Pfizer
PFE
PFE
2,959 hedge funds and large institutions have $99.7B invested in Pfizer in 2024 Q4 according to their latest regulatory filings, with 367 funds opening new positions, 926 increasing their positions, 1,455 reducing their positions, and 244 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,959
Holders Change
+73
Holders Change %
+2.53%
% of All Funds
39.39%
Holding in Top 10
41
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+2.5%
% of All Funds
0.55%
New
367
Increased
926
Reduced
1,455
Closed
244
Calls
$3.27B
Puts
$3.87B
Net Calls
-$599M
Net Calls Change
+$945M
Top Buyers
| 1 |
Charles Schwab
San Francisco,
California
|
+$672M |
| 2 |
BlackRock
New York
|
+$418M |
| 3 |
SV
Starboard Value
New York
|
+$408M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$181M |
| 5 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$144M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$630M |
| 2 |
Millennium Management
New York
|
-$330M |
| 3 |
Amundi
Paris,
France
|
-$290M |
| 4 |
JPMorgan Chase & Co
New York
|
-$279M |
| 5 |
Barclays
London,
United Kingdom
|
-$271M |
